74 related articles for article (PubMed ID: 35296132)
1. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
2. CSC
Ortiz RC; Amôr NG; Saito LM; Santesso MR; Lopes NM; Buzo RF; Fonseca AC; Amaral-Silva GK; Moyses RA; Rodini CO
Sci Rep; 2024 May; 14(1):10583. PubMed ID: 38719848
[TBL] [Abstract][Full Text] [Related]
3. DSPP-MMP20 gene silencing downregulates cancer stem cell markers in human oral cancer cells.
Nikitakis NG; Gkouveris I; Aseervatham J; Barahona K; Ogbureke KUE
Cell Mol Biol Lett; 2018; 23():30. PubMed ID: 30002682
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study.
Xu W; Wang Y; Qi X; Xie J; Wei Z; Yin X; Wang Z; Meng J; Han W
Sci Rep; 2017 Mar; 7():43907. PubMed ID: 28262804
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Tumor Resection and Radiotherapy on the Expression of Stem Cell Markers (CD44 and CD133) in Patients with Squamous Cell Carcinoma.
Paya L; Rafat A; Talebi M; Aghbali A; Shahidi N; Nejati B; Emamverdizadeh P; Nozad Charoudeh H
Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):92-99. PubMed ID: 38680713
[No Abstract] [Full Text] [Related]
6. Correlation of CD133 and Oct-4 expression with clinicopathological and demographic parameters in oral squamous cell carcinoma patients.
Singh A; Srivastava AN; Akhtar S; Siddiqui MH; Singh P; Kumar V
Natl J Maxillofac Surg; 2018; 9(1):8-13. PubMed ID: 29937653
[TBL] [Abstract][Full Text] [Related]
7. Expression of circulating tumour cells in oral squamous cell carcinoma: An
Sahana NS; Yadava ST; Choudhary B; Ravindran F; Khatoon H; Kulkarni M
J Oral Maxillofac Pathol; 2023; 27(3):489-493. PubMed ID: 38033976
[TBL] [Abstract][Full Text] [Related]
8. Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
Ma H; Jin S; Yang W; Tian Z; Liu S; Wang Y; Zhou G; Zhao M; Gvetadze S; Zhang Z; Hu J
J Cancer; 2017; 8(12):2384-2393. PubMed ID: 28819442
[No Abstract] [Full Text] [Related]
9. [Cancer stem cells in oral squamous cell carcinoma. Literature review].
Rodríguez-Vargas MP; Alvarado-Garnica H; Gutiérrez-Verdín LD; Villanueva-Sánchez FG; García-Contreras R
Rev Cient Odontol (Lima); 2022; 10(2):e106. PubMed ID: 38389655
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of SOX2 in OKC and ameloblastoma: A comparative study.
Pereira T; Shetty SJ; Punjabi V; Vidhale RG; Gotmare SS; Kamath P
J Oral Maxillofac Pathol; 2023; 27(4):685-692. PubMed ID: 38304494
[TBL] [Abstract][Full Text] [Related]
11. SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.
Sacco A; Battaglia AM; Santamaria G; Buffone C; Barone S; Procopio A; Lavecchia AM; Aversa I; Giorgio E; Petriaggi L; Cristofaro MG; Biamonte F; Giudice A
PLoS One; 2023; 18(12):e0293475. PubMed ID: 38096163
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of cancer stem cell markers and pro-inflammatory cytokine IL-1β in the oral squamous cell carcinoma and oral submucosal fibrosis.
Awasthi S; Ahmad S; Gupta R; Iqbal MS; Ahmad A
Int J Health Sci (Qassim); 2023; 17(6):28-38. PubMed ID: 37929238
[TBL] [Abstract][Full Text] [Related]
13. Role of hypoxia and epithelial-mesenchymal transition in the formation and maintenance of oral cancer stem cells in oral squamous cell carcinomas and metastatic lymph node: An immunohistochemical analysis.
Varsha VK; Savita JK; Girish HC; Shyamala K
J Oral Maxillofac Pathol; 2023; 27(2):307-314. PubMed ID: 37854934
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma.
Kim JH; Lee KW; Ahn DG; Oh KY; Yoon HJ
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825596
[TBL] [Abstract][Full Text] [Related]
15. Developments on the Smart Hydrogel-Based Drug Delivery System for Oral Tumor Therapy.
Zhao Y; Ran B; Xie X; Gu W; Ye X; Liao J
Gels; 2022 Nov; 8(11):. PubMed ID: 36421563
[TBL] [Abstract][Full Text] [Related]
16. High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High-Risk Population of Pakistan.
Adnan Y; Ali SMA; Farooqui HA; Kayani HA; Idrees R; Awan MS
Int J Surg Oncol; 2022; 2022():9990489. PubMed ID: 35296132
[TBL] [Abstract][Full Text] [Related]
17. SHH Expression Is Significantly Associated With Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma.
Cierpikowski P; Lis-Nawara A; Bar J
Anticancer Res; 2021 Nov; 41(11):5405-5413. PubMed ID: 34732409
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
